Point72 Asset Management, L.P. - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$5,329,629
+1131456.1%
277,296
+1459352.6%
0.02%
Q2 2023$471
-100.0%
19
-100.0%
0.00%
-100.0%
Q4 2022$9,535,284
-53.6%
240,790
+63.3%
0.03%
-69.5%
Q3 2020$20,539,000
+344.9%
147,441
+275.3%
0.10%
+337.5%
Q4 2019$4,617,000
-75.8%
39,282
-82.3%
0.02%
-79.5%
Q3 2019$19,081,000
+98.4%
221,954
+49.6%
0.12%
+134.0%
Q2 2019$9,619,000
-34.8%
148,376
-37.1%
0.05%
-25.4%
Q1 2019$14,750,000
-71.2%
235,959
-82.1%
0.07%
-73.2%
Q4 2018$51,285,000
-39.6%
1,318,707
-11.5%
0.25%
-28.6%
Q3 2018$84,967,000
+1152.5%
1,490,642
+1654.5%
0.35%
+1196.3%
Q2 2018$6,784,000
-82.3%
84,962
-80.8%
0.03%
-83.1%
Q1 2018$38,376,000
-32.2%
442,782
-46.0%
0.16%
-34.4%
Q4 2017$56,589,000
+14.7%
819,661
+51.0%
0.24%
+10.9%
Q3 2017$49,343,000
+65.3%
542,952
+35.4%
0.22%
+31.7%
Q2 2017$29,846,000
+4.8%
400,989
+31.9%
0.17%
+5.0%
Q1 2017$28,485,000
+78.0%
304,000
+38.1%
0.16%
+42.0%
Q4 2016$16,000,000
+1069.6%
220,200
+1580.9%
0.11%
+1020.0%
Q3 2016$1,368,000
-93.1%
13,100
-95.1%
0.01%
-92.6%
Q2 2016$19,878,000
-23.5%
269,500
-41.7%
0.14%
-32.2%
Q1 2016$25,998,000
+202.8%
462,100
+263.3%
0.20%
+180.3%
Q4 2015$8,587,000
-53.0%
127,200
-67.7%
0.07%
-50.3%
Q3 2015$18,264,000
+8.2%
393,700
+25.3%
0.14%
+22.2%
Q2 2015$16,884,000314,1160.12%
Other shareholders
NEVRO CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 403,424$46,950,0006.74%
HealthCor Management, L.P. 529,230$61,592,0002.66%
Sante Capital Fund, LP 18,963$2,207,0002.04%
Jackson Square Partners, LLC 2,452,497$285,421,0001.81%
Altium Capital Management LP 51,000$5,935,0001.56%
Rock Springs Capital Management LP 635,700$73,983,0001.56%
PFM Health Sciences, LP 392,786$45,712,0001.34%
Redmile Group, LLC 542,932$63,186,0001.10%
Connacht Asset Management LP 13,555$1,578,0001.02%
Integral Health Asset Management, LLC 30,000$3,491,0001.00%
View complete list of NEVRO CORP shareholders